Takeda Ventures, Inc. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of BiomX Inc (PHGE.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BiomX Inc (PHGE.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BiomX Inc (PHGE.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in BiomX Inc (PHGE). Other recent insider transactions involving BiomX Inc (PHGE) include a net sale of 0 shares made by Assaf Oron , and a net purchase of 348,000 shares made by Orbimed Israel Biofund Gp Limited Partnership .

In summary, during the past 3 months, insiders sold 0 shares of BiomX Inc (PHGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,914 shares of BiomX Inc (PHGE) were sold and 358,914 shares were bought by its insiders, resulting in a net purchase of 348,000 shares.

BiomX Inc (PHGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 485,250 shares, with a net purchase of 485,250 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 126,230 shares made by Samuel C. Blackman , a net sale of 149,055 shares made by Jeremy Bender , and a net sale of 106,267 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 219,672 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 219,672 shares. During the past 18 months, 479,465 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,765,219 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in Calithera Biosciences Inc (CALA). Other recent insider transactions involving Calithera Biosciences Inc (CALA) include a net sale of 121,333 shares made by Deepika Pakianathan ,

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 121,333 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 121,333 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.